Yahoo Web Search

Sign In

Search results

  1. www.verywellhealth.com › cancer-antigen-2729-430607What Is the Cancer Antigen 27.29 Test? - Verywell Health

    Mar 14, 2022 · The CA 27.29 test is primarily used to monitor stage 4 metastatic breast cancer and less commonly to detect recurrence in people previously treated for early-stage breast cancer. A higher antigen level corresponds to recurrence, and a lower antigen level corresponds to treatment response.

  2. Images

    • Staging & Grade - Breast Cancer | Johns Hopkins Pathology
    • What Are The Symptoms Of Stage 4 Breast Cancer - BreastCancerTalk.net
    • Ranges: April 2017
    • The Clinical Relevance of Rising CA-125 Levels Within the Normal Range ...

    View all

  3. emedicine.medscape.com › article › 2087535-overviewCA 27-29: Reference Range, Interpretation, Collection and Panels

    Feb 13, 2024 · Cancer antigen 27-29 (CA 27-29) is used to predict early recurrence of disease in women with treated carcinoma of the breast. The reference range of serum CA 27-29 is less than 38...

  4. www.cancercenter.com › tumor-markers › ca-27-29Cancer Antigen 27.29 (CA 27.29): Tumor Marker Blood Test

    Jun 7, 2023 · A CA 27.29 blood test looks for a specific type of tumor marker produced by the MUC1 gene. Elevated levels of this type of cancer antigen may be found in patients with metastatic breast cancer, meaning breast cancer that’s spread to distant areas of the body.

  5. People also ask

  6. connect.mayoclinic.org › discussion › ca-27-29CA 27-29 numbers rising: Does anyone else have an issue like ...

    May 16, 2019 · My cancer was stage 1 and so none of this applies and the CA 27–29 should not be used as a tool for diagnosing malignancy. Also, unnecessary tests are done that are expensive and that only frighten the patient. Also, it is my understanding that for the CA 27-29, the initial reading after surgery may be a bit high, but seems to decline after that.

  7. ascopubs.org › doi › 10Significance of CA 27.29 (MUC 1 glycoprotein) levels in ...

    Methods: After IRB approval, we conducted a retrospective chart review of 392 patients with breast cancer who had regular monitoring of CA 27.29 levels following the diagnosis of breast cancer. A total of 2671 values of CA 27.29 were evaluated from our institution over the past 5 years (2003–2008).

    • V. Ghai, H. A. Harvey, K. K. Abbi, A. Barochia, C. Bhardwaj, L. M. Demers
    • 2009

  8. www.labcorp.com › tests › 140293140293: Cancer Antigen (CA) 27.29 | Labcorp

    An elevated serum CA 27.29 level in patients in remission of stage II or III breast cancer provided a positive predictive value of 83.3% for recurrent disease, with an average lead time of 5.3 months before recurrence was clinically established.

  9. ascopubs.org › doi › 10Utility of CA 27.29 levels at the time of breast cancer ...

    May 20, 2014 · CA 27.29 levels ranged from 4.45 Units/mL to 127.6 Units/ml with a mean value of 23.4 Units/mL. Only fifteen of the 183 patients (8.2%) had an elevated preoperative CA 27.29 level, defined as greater than 37.7 Units/mL at our institution.